IONQ 1-day forecast by DeepSeek
DeepSeek's 1-day forecast for IONQ, made 2026-10-19: expected range $28.25 to $33.25 at 58% confidence. Settled at $31.49: direction called incorrectly, score 30.4.
| Asset | IONQ |
|---|---|
| Model | DeepSeek |
| Recorded by | Forecastnest |
| Forecast made | |
| Horizon | 1-day (Equity / ETF 1D: the stored target below is authoritative; it may be a session close or an intraday instant.) |
| Window closes | |
| Price when asked | $30.89 |
| Price the model reported | $30.84 |
| Expected range | $28.25 to $33.25 |
| Confidence | 58% |
| Prompt style | No data |
| Status | Settled |
| Actual close | $31.49 |
| Traded range in the window | $30.19 to $32.17 |
| Result | Direction called incorrectly |
| Score | 30.4 of 100 |
The model's reasoning
(1) Price and intraday evidence: the latest verified regular-session print is $30.84 at 2026-10-19T15:53:00+02:00 from https://www.finanzen.net/aktien/ionq-aktie, a delayed regular-session quote and not an exact 17:35 UTC print. A partial-session snapshot from https://www.itiger.com/stock/IONQ shows open $32.35, high $32.43, low $30.29 and cumulative volume 16,793,000, but its timestamp is not displayed, so freshness cannot be verified; the snapshot implies a price near $30.9 and confirms that the Monday gap-up faded. Pre-event close on 2026-10-13 was $34.73, so the observed move from that close to $30.84 is -11.2%. The elapsed move inside the scored window is about -1.4% from Friday's $31.28 close; the forecast below concerns the remaining hours through 2026-10-20T17:35Z.
(2) Daily OHLCV, oldest to newest, split-adjusted NYSE regular-session bars in USD with volume in shares: 2026-10-12 O 38.79 H 38.81 L 35.89 C 36.27 V 31,306,472; 2026-10-13 O 35.82 H 35.99 L 34.48 C 34.73 V 22,922,148; 2026-10-14 O 33.15 H 33.39 L 31.05 C 31.42 V 40,186,610; 2026-10-15 O 30.55 H 34.36 L 30.03 C 34.35 V 46,885,527; 2026-10-16 O 33.03 H 33.64 L 31.11 C 31.28 V 27,991,993. The path is bearish: 12 October closed near its low, 14 October closed near its low on heavy volume, 15 October produced a large high-volume reversal closing at its high, and 16 October erased that bounce and again closed near its low. On 19 October the stock gapped up to $32.35 but faded to the low-$30s, a bearish intraday rejection.
(3) Context: return_5d_pct = -21.58%, calculated from the 2026-10-16 close of $31.28 versus the 2026-10-09 close of $39.89. high_20d = $47.91, low_20d = $30.03, and avg_volume_20d = 27,004,961 shares, measured over the 20 completed sessions from 2026-09-21 through 2026-10-16. The current price sits about 2.7% above the 20-day low and about 35.6% below the 20-day high, so it is compressed against support after a violent de-rating.
(4) Sources and conventions: daily OHLCV and 20-session statistics come from https://stockanalysis.com/stocks/ionq/history/; the venue is NYSE, the daily boundary is the 09:30-16:00 America/New_York regular session, prices are split-adjusted USD OHLC rather than dividend-adjusted closes, and volume is in shares. The intraday snapshot from https://www.itiger.com/stock/IONQ is a separate partial-session reading and is not mixed into the completed daily bars or the 20-session average. Because the itiger snapshot has no displayed as-of time, its cumulative volume cannot be compared directly with the full-day 20-session average, and relative intraday volume cannot be established with confidence.
(5) Market regime and thesis: IONQ is a high-beta speculative quantum name in a sharp downtrend, with five-session damage of -21.58%, a 35.6% drawdown from the 20-day high, and a failed Monday gap-up. The near-term path of least resistance remains lower because sellers have repeatedly sold intraday rallies and the stock is making lower daily highs since late September. The broader backdrop is also fragile: a technology selloff, September CPI at 3.7% and concerns about AI-infrastructure spending have compressed long-duration growth stocks, as described by https://markets.businessinsider.com/news/stocks/quantum-stocks-sank-up-to-9-in-tech-selloff-can-they-bounce-back-this-week-1036639411.
(6) Price-range justification: the last five daily absolute moves average roughly 8.2%, so a 24-hour range of about ±8% around $30.84 is reasonable for this volatility. The range is deliberately skewed lower, from $28.25 to $33.25, because the immediate evidence is a failed gap-up and a close near the session low. Support sits at the 15 October low of $30.03 and the 19 October low of $30.29; a break there exposes the high-$20s. Resistance sits at the 19 October high of $32.43 and the 16 October high of $33.64.
(7) Catalysts: the dominant verified event is IonQ's $2.0 billion equity offering, priced on 2026-10-14 at $40.00 per share for 20.5 million common shares, with 29.5 million pre-funded warrants and warrants for 100 million shares at $69.46, according to https://investors.ionq.com/news/news-details/2026/IonQ-Announces-Pricing-of-2.0-Billion-Equity-Offering/default.aspx and https://www.tipranks.com/stocks/ionq; the offering closed on 2026-10-16. IonQ also announced an all-stock acquisition of Elisity valued at up to $1.3 billion on 2026-10-12. These are fundamental dilution and capital-allocation events, not merely sentiment, and the warrant overhang can cap rallies. No IonQ earnings release is scheduled inside the window; the next estimated report is 2026-11-04 after the close, per https://stockanalysis.com/stocks/ionq/statistics/. Broader earnings from Meta and Tesla on 2026-10-21 fall outside the scored window, and SpaceX's 2026-10-20 report is likely after the US close and therefore at or beyond the window end. There is no verified company-specific catalyst due inside the next 24 hours.
(8) Counter-evidence: the strongest bullish evidence is the 15 October session, which reversed from $30.03 to close at $34.35, up 9.33% on 46.9 million shares, about 1.7 times the 20-day average; that is a credible high-volume reversal and shows dip buyers can appear quickly. Monday's premarket strength also showed initial demand. The $2 billion raise removes near-term financing risk, and the average analyst target remains far above the current price. However, the 15 October reversal failed immediately on 16 October, and Monday's gap-up was sold, so the reversal evidence has not been confirmed by follow-through.
(9) Invalidation: the mild-bearish thesis would be undermined by a daily close above $33.64, the 2026-10-16 high, which would show that buyers have reclaimed the post-offering breakdown area and turned the short-term structure neutral-to-up. Conversely, a daily close below $30.03, the 2026-10-15 low, would confirm the breakdown and keep the high-$20s in play.
(10) Confidence: 58%. The direction is supported by the failed gap-up, the close near lows, the dilution overhang and the absence of a near-term company catalyst, but confidence is capped by missing exact quote freshness, the 15 October high-volume reversal, high beta and the possibility of a violent oversold bounce or short-covering rally.
Other models on the same question
| Model | Expected range | Confidence | Result | Score |
|---|---|---|---|---|
| Gemini 3 Pro | $21.50 to $23.50 | 55% | No directional call | 1.5 |
| Perplexity | $28.50 to $33.50 | 42% | No directional call | 50.7 |
| Grok 4.5 | $29.50 to $32.50 | 42% | No directional call | 51.3 |
| Muse Spark 1.1 | $28.50 to $32.20 | 38% | Direction called incorrectly | 34.3 |
| GPT-6 | $28.10 to $33.20 | 55% | Direction called incorrectly | 31.1 |
How this forecast is measured
Sends only the baseline price and the output format; your AI researches the asset itself. Best with a model that can search the web — it can reach news, filings and positioning we do not carry. Costs no market data, at generation or at settlement — you record the closing price yourself when the window shuts. The monthly allowance is what a membership buys, not a data bill.
Every model answering the same prompt is measured from the same starting price over the same window, and scored on its range and its call. How scoring works · All shared research.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.